My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Karuna Therapeutics, Inc. - Common Stock (NQ:KRTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 15, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Karuna Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Premarket Moves: Nike Dips 11%, Karuna Therapeutics Soars 48% ↗

December 22, 2023

Friday has seen several stocks make notable moves ahead of the market opening, with Nike (NKE) and Karuna Therapeutics (KRTX) capturing the most attention.

Via Talk Markets

Karuna Stock Soars On Bristol Myers' $14 Billion Takeover ↗

December 22, 2023

Karuna is working on treatments for schizophrenia and Alzheimer's disease psychosis.

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 22, 2023

Via Benzinga

Where Karuna Therapeutics Stands With Analysts ↗

December 12, 2023

Via Benzinga

The Latest Analyst Ratings for Karuna Therapeutics ↗

November 20, 2023

Via Benzinga

Karuna Therapeutics Says Its Antipsychotic Candidate Shows Favorable Cardiovascular Safety Profile In Schizophrenia Patients ↗

November 17, 2023

Karuna Therapeutics Inc (NASDAQ: KRTX) released results from its Phase 1b open-label, eight-week inpatient trial evaluating the effect of KarXT (xanomeline-trospium) on 24-hour ambulatory blood...

Via Benzinga

Analyst Expectations for Karuna Therapeutics's Future ↗

November 03, 2023

Via Benzinga

What 9 Analyst Ratings Have To Say About Karuna Therapeutics ↗

September 28, 2023

Via Benzinga

Analyst Expectations for Karuna Therapeutics's Future ↗

September 08, 2023

Via Benzinga

Karuna Takes A Big Step In Schizophrenia Treatment. Shares Jump Higher. ↗

September 28, 2023

Karuna Therapeutics says it could have the first new mechanism for schizophrenia treatment in decades.

Via Investor's Business Daily

10 Analysts Have This to Say About Karuna Therapeutics ↗

August 22, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023 ↗

August 22, 2023

Via Benzinga

The Latest Analyst Ratings for Karuna Therapeutics ↗

August 04, 2023

Via Benzinga

The Latest Analyst Ratings for Karuna Therapeutics ↗

July 13, 2023

Via Benzinga

Where Karuna Therapeutics Stands With Analysts ↗

June 01, 2023

Via Benzinga

The Latest Analyst Ratings for Karuna Therapeutics ↗

May 16, 2023

Via Benzinga

Karuna Therapeutics's Return On Capital Employed Overview ↗

May 12, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023 ↗

July 20, 2023

Via Benzinga

What Are Latest Investor Thoughts On Karuna Therapeutics? Analyst Sees Buying Opportunity ↗

July 14, 2023

William Blair notes increasing investor inbounds on Karuna Therapeutics Inc (NASDAQ: KRTX) given the recent pullback, as the stock is down 13% off June 2023 highs and 25% off 52-week highs

Via Benzinga

3 Biotech Buyout Targets to Watch ↗

April 29, 2023

The trio all have late-stage therapies with blockbuster potential.

Via The Motley Fool

Why Shares of Karuna Therapeutics Were Up Wednesday ↗

March 22, 2023

The clinical-stage biotech announced positive trial results for its lead therapy.

Via The Motley Fool

Analyst Expectations for Karuna Therapeutics's Future ↗

March 21, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 06, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

June 29, 2023

Via Benzinga

Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance ↗

May 09, 2023

Via Benzinga

PureTech Health FY22 Revenue Declines 10.2% YoY, Here Are The Details ↗

April 28, 2023

PureTech Health plc (NASDAQ: PRTC) (LSE:PRTC) released its results for the year ended December 31, 2022, revealing revenue of $15.6 million, a decrease of 10.2% compared to $17.4 million in 2021....

Via Benzinga

Travelzoo, Semler Scientific, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday ↗

March 22, 2023

U.S. stocks traded mostly higher, with the Dow Jones gaining around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 22, 2023

Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday.

Via Benzinga

Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 21, 2023

Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share.

Via Benzinga

ENPH Stock Price Prediction: Can Enphase Energy Really Hit $225? ↗

March 20, 2023

Enphase Energy (ENPH) stock is continuing to rise higher on Monday after an upgrade on Friday gave the company's shares a boost.

Via InvestorPlace

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.